# V1 Empirics Check — moonshotai/kimi-k2.5 (Variant A)

**Model:** moonshotai/kimi-k2.5
**Variant:** A
**Date:** 2026-03-23T07:39:33.860263

---

**Referee Report**

**Manuscript:** "The SNAP Buffer: Cross-Program Data Coordination and Medicaid Enrollment Resilience During the 2023--2024 Unwinding"

**Recommendation:** Major Revision Required (with possibility of rejection if Essential Point #1 cannot be addressed)

---

### 1. Idea Fidelity

The paper pursues the core research question outlined in the manifest—whether SNAP-Medicaid data coordination buffered states against coverage losses during the unwinding—but deviates substantively from the proposed empirical strategy and outcome definition. The original design specified **T-MSIS provider claims** as the primary outcome (227M rows, 2018–2024), emphasizing "healthcare delivery consequences" and "claims continuity" as the novel contribution. The submitted manuscript instead uses **CMS Monthly Enrollment Reports** (state-level enrollment stocks) from 2019–2024. This substitution fundamentally alters the paper's contribution: it moves from measuring downstream impacts on healthcare utilization to documenting administrative burden in enrollment retention (a well-studied phenomenon in the Medicaid unwinding literature). Additionally, the manifest identified 19 e14-waiver states, while the paper uses 17 without explanation. The manuscript must either reconcile these discrepancies or justify this scope reduction explicitly.

---

### 2. Summary

This paper examines whether Section 1902(e)(14)(A) waivers allowing automatic Medicaid renewal based on SNAP enrollment records reduced coverage losses during the 2023–2024 Medicaid unwinding. Using a difference-in-differences design comparing 17 "waiver" states to 33 non-waiver states with common treatment timing (April 2023), the authors find a statistically insignificant pooled effect of +0.95 percentage points on normalized enrollment but claim evidence of a delayed protective effect of 5–6.5 percentage points emerging six to twelve months post-unwinding. The paper argues that cross-program data coordination generates dynamic benefits that compound as administrative backlogs accumulate in non-waiver states.

---

### 3. Essential Points

**1. Critical Outcome Deviation and Misalignment of Claims**
The manuscript abandons the T-MSIS claims data central to the original research design and advertised contribution. The manifest explicitly promised to measure "healthcare delivery consequences" and "claims resilience"—outcomes that would demonstrate whether administrative data coordination actually preserved *access to care*, not merely insurance coverage. By substituting enrollment data, the paper cannot distinguish between intentional program retention (beneficiaries maintaining coverage) and mere administrative persistence (ineligible beneficiaries remaining enrolled due to auto-renewal). More seriously, the paper cannot speak to whether the SNAP buffer prevented disruption in healthcare *delivery* (e.g., prescription fills, behavioral health visits), which was the unique value proposition of the original idea. **Unless the authors can obtain T-MSIS or similar claims data, the paper must be reframed as a study of enrollment retention under administrative burden, abandoning claims to healthcare delivery impacts.** If claims data are unattainable, the contribution is significantly diminished relative to the existing unwinding literature (e.g., Sommers et al., KFF reports) that already documents enrollment losses comprehensively.

**2. Violation of Parallel Trends and Endogenous Selection**
The event study estimates (Table 3) reveal significant pre-trends: waiver states exhibit positive and statistically significant coefficients at 12, 9, and 6 months pre-treatment (0.0257, 0.0092, and 0.0049 respectively), indicating that waiver states were already retaining enrollment better than non-waiver states before the unwinding began. This is consistent with endogenous selection: states with superior administrative capacity (which likely managed renewals better regardless of the waiver) were the ones that applied for and received E14 approvals. The DiD design therefore conflates the effect of the waiver with underlying administrative quality. The current identification strategy is not credible without addressing these diverging trends. The authors must implement **synthetic difference-in-differences** (Arkhangelsky et al., 2021), **interactive fixed effects** (Bai, 2009), or a **detrending approach** (e.g., Borusyak et al., 2024) to adjust for the pre-existing differential trajectories. Alternatively, if the pre-trends reflect differential seasonality, the authors should demonstrate that the patterns are stable across multiple pre-periods and include state-specific time trends.

**3. Selective Reporting and Statistical Significance**
The text makes strong causal claims about "5--6.5 percentage points of baseline enrollment by months six through twelve," but these claims are unsupported by the reported event study coefficients in Table 3. The table shows coefficients of 0.0247 (SE 0.0198), 0.0179 (SE 0.0217), and 0.0101 (SE 0.0216) for months 6, 9, and 12—none of which approach statistical significance at conventional levels (p-values > 0.20). Moreover, the text cites months "seven through eight" (which are not reported in the table) as showing the peak effect of 6.5 percentage points. This selective presentation of results—highlighting substantively large but statistically imprecise point estimates while omitting the full trajectory and standard errors—undermines confidence in the empirical analysis. The authors must report complete event study graphs (with confidence intervals), correct the textual claims to reflect statistical precision honestly, and refrain from presenting pooled "months 6–12" averages unless they can demonstrate these are pre-specified aggregates with adequate power.

---

### 4. Suggestions

**Addressing the Claims Data Shortfall**
If T-MSIS data are truly inaccessible (likely due to the 18-24 month lag in public availability), the authors should attempt to obtain **Medicaid managed care encounter data** or **all-payer claims databases (APCD)** for a subset of states (e.g., 10–15 states with available APCD) to validate whether enrollment retention translated into claims continuity. If even this is infeasible, the paper should use the **claims-per-beneficiary** ratio from the T-MSIS data that *is* available through 2022 (pre-unwinding) to test for differential trends in utilization intensity, providing at least indirect evidence on healthcare delivery. Absent any claims data, the title and abstract must drop references to "healthcare delivery" and "claims resilience" and position the paper narrowly within the administrative burden literature.

**Strengthening Identification Given Pre-Trends**
Given the clear pre-trends, I recommend the following robustness checks:
- **Synthetic Control Method:** Construct a synthetic counterfactual for each waiver state using weighted combinations of non-waver states that match pre-trends exactly. With only 17 treated units, this is computationally feasible and would provide a more credible counterfactual than the raw DiD.
- **Donut Hole Design:** Drop the immediate pre-period (January–March 2023) to ensure that anticipation effects or differential "ramping up" aren't driving the results.
- **Triple-Difference:** Leverage the variation in SNAP penetration (share of Medicaid enrollees also on SNAP) across states. The treatment effect should be larger in states with higher dual enrollment rates. This tests the mechanism and provides a "dose-response" check that may be less confounded by overall administrative capacity.
- **Matching on Pre-Trends:** Use Coarsened Exact Matching or propensity score matching on the pre-trend slopes (e.g., enrollment growth 2021–2023) rather than levels to balance the comparison groups.

**Interpretation of "Delayed Onset"**
The mechanism posited—that the effect grows over time due to backlogs—is plausible but competes with alternative explanations:
- **Calendar Alignment:** As noted in the text, SNAP recertifications occur on different schedules. However, this would predict a gradual *step-function* increase aligned with recertification waves, not a smooth linear increase. The authors should test for jumps in specific months corresponding to SNAP recertification cycles.
- **Differential Churn:** The stock enrollment measure masks *flows* (disenrollment and re-enrollment). Waiver states may simply have slower disenrollment processing rather than true retention. The authors should request or construct **disenrollment rate** data (flow rather than stock) to test whether the SNAP buffer reduced exits or merely delayed paperwork processing.
- **Substitution of Disenrollment Types:** Waiver states may have substituted procedural disenrollments (paperwork losses) with ineligibility-based disenrollments later in the period. Examining the *composition* of disenrollments (if available via CMS Performance Indicators) would clarify whether the buffer preserved coverage for eligible beneficiaries or simply delayed eligibility redeterminations.

**Clarifying Treatment Definition**
The manuscript uses 17 states while the manifest (and CBPP 2024) suggests 19 states received e14 waivers. The authors should clarify:
- Whether the discrepancy reflects timing (waivers approved after April 2023) or data availability.
- Whether the 17-state definition excludes states with "integrated eligibility systems" but not formal e14 waivers. The KFF 26-state definition (used in robustness) likely captures states with technical capacity but not necessarily the specific waiver authority used for ex parte renewal during the unwinding. The paper should explicitly map these overlapping definitions in a Venn diagram or appendix table.

**Power and Inference**
With only 17 treated clusters and clustered standard errors at the state level, the design is underpowered for modest effect sizes. The authors should:
- Report **effective degrees of freedom** adjustments (e.g., using the wild cluster bootstrap-t procedure given the small number of treated clusters).
- Present **Bayesian** or **conformal inference** methods that may be more appropriate with small-N treatment groups.
- Conduct **sensitivity analysis** for potential effect size bounds (e.g., using the method of Chernozhukov et al., 2013) given the imprecision.

**Heterogeneity Analysis**
If the main effect is indeed noisy, the paper would benefit from pre-specified heterogeneity analysis:
- **Expansion vs. Non-Expansion States:** The value of SNAP data may differ in states with less generous Medicaid eligibility (non-expansion states rely more heavily on SNAP as an eligibility pathway).
- **Baseline Ex Parte Capacity:** States with high pre-unwinding ex parte renewal rates may show smaller marginal effects of the SNAP waiver (ceiling effects).
- **Demographic Composition:** Using ACS data, test whether effects are larger in states with higher shares of vulnerable populations (limited English proficiency, housing instability) who face higher administrative burden.

**Policy Implications**
The conclusion argues that "30+ states without this capacity should build it." However, the evidence suggests that states with superior administrative capacity self-selected into waivers. Building data infrastructure in states with weaker baseline capacity may not yield the same returns observed in this selected sample. The policy recommendations should be tempered with this "external validity" caveat.

**Data and Replication**
The paper should clarify the exact API endpoint used (CMS Monthly Enrollment Reports have undergone retroactive revisions) and provide a data timeline showing when data were accessed. Given that unwinding enrollment data are subject to significant reporting lags and corrections, confirm that the data used are the "final" reconciled numbers or provide robustness to using preliminary vs. final data.

**Formatting and Presentation**
- Table 3 should include all monthly coefficients (not just selected intervals) with confidence intervals presented graphically in an event-study figure. The current sparse presentation invites cherry-picking concerns.
- The placebo test in Table 4 Panel D shows a marginally significant effect at April 2022 (p=0.07), further undermining confidence in the parallel trends assumption. This should be discussed explicitly as a limitation rather than buried in a robustness table.
- Standardized effect sizes (Appendix Table A1) classify a 0.0095 effect as "moderate positive" despite p=0.62. This classification is misleading and should be removed or recalibrated to account for statistical significance.

**Conclusion**
This paper addresses a timely and important question at the intersection of SNAP and Medicaid administration. However, the deviation from the planned claims-based analysis, the violation of parallel trends, and the selective reporting of noisy estimates currently prevent it from making a credible contribution. If the authors can address the pre-trend violations through synthetic control methods or obtain claims data to validate the healthcare delivery mechanism, the paper could represent a valuable addition to the literature on administrative burden and cross-program coordination. In its current form, however, the evidence does not support the strong causal claims made in the abstract and introduction.
